IL6 and osteoporosis: This pervasive inflammation is associated with an increased risk of osteoporosis, primarily due to the release of proinflammatory cytokines such as interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) (Lee et al., 2010; Wang and He, 2020).